Cardinal Capital Management Charles River Laboratories International, Inc. Transaction History
Cardinal Capital Management
- $668 Million
- Q2 2025
A detailed history of Cardinal Capital Management transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cardinal Capital Management holds 10,870 shares of CRL stock, worth $1.66 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
10,870
Previous 10,723
1.37%
Holding current value
$1.66 Million
Previous $1.61 Million
2.17%
% of portfolio
0.25%
Previous 0.25%
Shares
36 transactions
Others Institutions Holding CRL
# of Institutions
607Shares Held
53.6MCall Options Held
722KPut Options Held
847K-
Vanguard Group Inc Valley Forge, PA5.81MShares$888 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$777 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$655 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$365 Million0.07% of portfolio
-
Allspring Global Investments Holdings, LLC2.29MShares$350 Million0.63% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.77B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...